EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Circulating Tumor DNA in Head and Neck Squamous Cell Carcinoma: Association with Metabolic Tumor Burden Determined with FDG-PET/CT

Antti Silvoniemi iD, Jukka Laine, Katri Aro iD, Linda Nissi, Leif Bäck, Jukka Schildt iD, Jussi Hirvonen iD, Jaana Hagström iD, Heikki Irjala iD, Leena-Maija Aaltonen, Marko Seppänen, Heikki Minn

Cancers · 04.08.2023 · 15 (15) · 3970

DOI: 10.3390/cancers15153970 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancers, online erschienen am 04.08.2023. Verfasst von Antti Silvoniemi und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology-Head and Neck Surgery, Turku University Hospital, University of Turku, FI-20521 Turku, Finland. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Finnish Medical Foundation, The Finnish ORL-HNS Foundation, Cancer Society of Finland.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The detection of circulating tumor DNA (ctDNA) with next-generation sequencing (NGS) in venous blood is a promising tool for the genomic profiling of head and neck squamous cell carcinoma (HNSCC). The association between ctDNA findings and metabolic tumor burden detected with FDG-PET/CT imaging is of particular interest for developing prognostic and predictive algorithms in HNSCC.

Methods

Twenty-six prospectively enrolled HNSCC patients were eligible for further analysis. All patients underwent tumor tissue and venous liquid biopsy sampling and FDG-PET/CT before definitive oncologic treatment. An NGS-based commercial panel was used for a genomic analysis of the samples.

Results

Maximum variant allele frequency (VAF) in blood correlated positively with whole-body (WB) metabolic tumor volume (MTV) and total lesion glycolysis (TLG) (r = 0.510, p = 0.008 and r = 0.584, p = 0.002, respectively). A positive liquid biopsy was associated with high WB-TLG using VAF ≥ 1.00% or ≥5.00% as a cut-off value (p = 0.006 or p = 0.003, respectively). Additionally, ctDNA detection was associated with WB-TLG when only concordant variants detected in both ctDNA and tissue samples were considered.

Conclusions

A high metabolic tumor burden based on FDG imaging is associated with a positive liquid biopsy and high maximum VAF. Our findings suggest a complementary role of metabolic and genomic signatures in the pre-treatment evaluation of HNSCC.

Schlagwörter

Stichwörter der Autor:innen

FDG-PET/CTcfDNAcirculating tumor DNActDNAhead and neck cancerliquid biopsymetabolic tumor volumenext-generation sequencingtotal lesion glycolysisvariant allele frequency

Autor:innen und Institutionen

  • Department of Otorhinolaryngology-Head and Neck Surgery, Turku University Hospital, University of Turku, FI-20521 Turku, Finland.
  • Turku PET Centre, University of Turku, FI-20521 Turku, Finland.
  • Department of Pathology, Turku University Hospital, University of Turku, FI-20520 Turku, Finland.
  • Department of Otorhinolaryngology-Head and Neck Surgery, Helsinki University Hospital, University of Helsinki, FI-00029 Helsinki, Finland.
  • Department of Oncology, Turku University Hospital, University of Turku, FI-20521 Turku, Finland.
  • Department of Nuclear Medicine, HUS Diagnostic Center, Helsinki University Hospital, University of Helsinki, FI-00029 Helsinki, Finland.

ORCID-Profile: Antti Silvoniemi, Katri Aro, Jukka Schildt, Jussi Hirvonen, Jaana Hagström, Heikki Irjala

Förderung

  • Finnish Medical Foundation
  • The Finnish ORL-HNS Foundation
  • Cancer Society of Finland
  • Finnish Government Research Funds
  • Helsinki University Research Funds

Zitieren

APA

Silvoniemi, A., Laine, J., Aro, K., Nissi, L., Bäck, L., Schildt, J., Hirvonen, J., Hagström, J., Irjala, H., Aaltonen, L. M., Seppänen, M., & Minn, H. (2023). Circulating Tumor DNA in Head and Neck Squamous Cell Carcinoma: Association with Metabolic Tumor Burden Determined with FDG-PET/CT. Cancers, 15(15), 3970. https://doi.org/10.3390/cancers15153970

Vancouver

Silvoniemi A, Laine J, Aro K, Nissi L, Bäck L, Schildt J, et al. Circulating Tumor DNA in Head and Neck Squamous Cell Carcinoma: Association with Metabolic Tumor Burden Determined with FDG-PET/CT. Cancers. 2023;15(15):3970. doi:10.3390/cancers15153970

BibTeX
@article{Silvoniemi2023,
  author = {Silvoniemi, Antti and Laine, Jukka and Aro, Katri and Nissi, Linda and Bäck, Leif and Schildt, Jukka and Hirvonen, Jussi and Hagström, Jaana and Irjala, Heikki and Aaltonen, Leena-Maija and Seppänen, Marko and Minn, Heikki},
  title = {Circulating Tumor DNA in Head and Neck Squamous Cell Carcinoma: Association with Metabolic Tumor Burden Determined with FDG-PET/CT},
  journal = {Cancers},
  year = {2023},
  volume = {15},
  number = {15},
  pages = {3970},
  doi = {10.3390/cancers15153970}
}
Kostenlos starten →